Matches in Wikidata for { <http://www.wikidata.org/entity/Q91792483> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q91792483 description "2019 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q91792483 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91792483 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91792483 description "scientific article published on 11 July 2019" @default.
- Q91792483 description "wetenschappelijk artikel" @default.
- Q91792483 description "наукова стаття, опублікована 11 липня 2019" @default.
- Q91792483 name "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 name "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 type Item @default.
- Q91792483 label "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 label "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 prefLabel "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 prefLabel "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 P1433 Q91792483-FFB1E4F8-FE87-41FD-AA78-F0A7C9F840AF @default.
- Q91792483 P1476 Q91792483-7BA2BFEF-E0F8-42EE-904D-981ED7DB9DB1 @default.
- Q91792483 P2093 Q91792483-1FA3F34F-131B-4285-9BE8-3EA4E3982B9E @default.
- Q91792483 P2093 Q91792483-6064A26F-DABD-43CC-996E-FB9CCE6FF18F @default.
- Q91792483 P2093 Q91792483-6E9216C8-12D2-433B-BB79-33E82943DA22 @default.
- Q91792483 P2093 Q91792483-77E3BAA6-C343-428C-B839-35DF29DDB04B @default.
- Q91792483 P2093 Q91792483-9D145F22-ACF1-4E7B-BEAE-25E0B37D21D2 @default.
- Q91792483 P2093 Q91792483-ACD9908A-3910-495C-93EE-97913216357B @default.
- Q91792483 P2093 Q91792483-B19A59D3-607B-4AF5-BC47-284B0E8972C2 @default.
- Q91792483 P2093 Q91792483-B23E26B1-6087-4BF5-91AD-4F33ACF2F173 @default.
- Q91792483 P2093 Q91792483-D26EEAA1-E7DA-440A-A626-6C165F6314D3 @default.
- Q91792483 P2093 Q91792483-E171A780-8A56-49C3-A54C-FDA0BB5018FA @default.
- Q91792483 P2093 Q91792483-EF4F5442-A32B-466E-AEAA-E8D45479506B @default.
- Q91792483 P2093 Q91792483-FA6814E8-69CC-4906-B6D8-63916B05EBAD @default.
- Q91792483 P31 Q91792483-C2C0E69D-401A-4DF4-8C63-D95DF04FC9F7 @default.
- Q91792483 P356 Q91792483-82C4FDFB-3BFF-401D-B916-FF9DD391B23B @default.
- Q91792483 P577 Q91792483-37FC2F92-A05F-4F1F-AFE0-8FBC175CFC4A @default.
- Q91792483 P698 Q91792483-0B00DA9F-85EB-40E3-816D-897F3143D71D @default.
- Q91792483 P921 Q91792483-19D8C4E3-9CB4-4341-810D-8C1B88E38503 @default.
- Q91792483 P921 Q91792483-4A43051E-8F7E-44B7-85D7-967061630C52 @default.
- Q91792483 P921 Q91792483-C11699AE-AAB3-417C-8A7A-8658036F95D6 @default.
- Q91792483 P932 Q91792483-B0DAC76A-D8CE-4E64-A629-33AD16B810CE @default.
- Q91792483 P356 JAMAONCOL.2019.1478 @default.
- Q91792483 P698 31294749 @default.
- Q91792483 P1433 Q22079683 @default.
- Q91792483 P1476 "Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial" @default.
- Q91792483 P2093 "Adrianus J de Langen" @default.
- Q91792483 P2093 "Anna-Larissa N Niemeijer" @default.
- Q91792483 P2093 "Daphne W Dumoulin" @default.
- Q91792483 P2093 "Ferry Lalezari" @default.
- Q91792483 P2093 "Heike M U Peulen" @default.
- Q91792483 P2093 "Idris Bahce" @default.
- Q91792483 P2093 "Jeltje F de Vries" @default.
- Q91792483 P2093 "Joachim G J V Aerts" @default.
- Q91792483 P2093 "Kim Monkhorst" @default.
- Q91792483 P2093 "Paul Baas" @default.
- Q91792483 P2093 "Vincent van der Noort" @default.
- Q91792483 P2093 "Willemijn S M E Theelen" @default.
- Q91792483 P31 Q13442814 @default.
- Q91792483 P356 "10.1001/JAMAONCOL.2019.1478" @default.
- Q91792483 P577 "2019-07-11T00:00:00Z" @default.
- Q91792483 P698 "31294749" @default.
- Q91792483 P921 Q13896859 @default.
- Q91792483 P921 Q42824440 @default.
- Q91792483 P921 Q47912 @default.
- Q91792483 P932 "6624814" @default.